Cristian Rivera Foundation Gala raises millions to advance DIPG research | amNewYork
Briefly

Cristian Rivera Foundation Gala raises millions to advance DIPG research | amNewYork
"This disease does not wait. It does not offer grace. It takes young lives in the blink of an eye. DIPG remains almost universally fatal, striking children in their most innocent years and leaving families with heartbreak that defies language. The urgency is staggering, and the need for action is immediate. A Night Built on Purpose The Cristian Rivera Foundation has stepped into that darkness with unshakeable resolve."
"Its founder, John Gungie Rivera, transformed the unimaginable grief of losing his son, Cristian, into a movement that has already altered the landscape of DIPG research. This is not an organization of passive sympathy. This is a force of will. More than $3 million has been raised and directed toward cutting-edge clinical trials at Memorial Sloan Kettering, Weill Cornell, and Mount Sinai Kravis Children's Hospitalthe very institutions pushing the boundaries of what modern medicine can attempt."
A gala at Cipriani Wall Street gathered donors, clinicians, and families to confront Diffuse Intrinsic Pontine Glioma (DIPG) with urgency and purpose. DIPG is an almost universally fatal brainstem tumor that strikes children and leaves families devastated. The Cristian Rivera Foundation channels grief into action by funding clinical trials and providing direct family support. More than $3 million has been raised for trials at Memorial Sloan Kettering, Weill Cornell, and Mount Sinai Kravis Children's Hospital. The foundation emphasizes science-driven hope, rapid translational research, and ensuring families are not navigating treatment alone.
Read at www.amny.com
Unable to calculate read time
[
|
]